Division of Geriatrics Department of Medicine Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada.
Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada.
J Am Heart Assoc. 2020 Sep 15;9(18):e016003. doi: 10.1161/JAHA.119.016003. Epub 2020 Sep 2.
Background Assessment of atherosclerotic cardiovascular disease (ASCVD) risk is crucial for prevention and management, but the performance of the pooled cohort equations in older adults with frailty and multimorbidity is unknown. We evaluated the pooled cohort equations in these subgroups and the impact of competing risks. Methods and Results In 4249 community-dwelling adults, aged ≥65 years, from the CHS (Cardiovascular Health Study), we calculated 10-year risk of hard ASCVD. Frailty was determined using the Fried phenotype. Latent class analysis was used to identify individuals with multimorbidity patterns using chronic conditions. We assessed discrimination using the C-statistic and calibration by comparing predicted ASCVD risks with estimated risk using cause-specific and cumulative incidence models, by multimorbidity patterns and frailty status. A total of 917 (21.6%) participants had an ASCVD event, and 706 (16.6%) had a competing event of death. C-statistic was 0.68 in men and 0.69 in women; calibration was good when compared with cause-specific and cumulative incidence estimated risks (males, -0.1% and 3.3%; females, 0.6% and 1.4%). Latent class analysis identified 4 patterns: minimal disease, cardiometabolic, low cognition, musculoskeletal-lung depression. In the cardiometabolic pattern, ASCVD risk was overpredicted compared with cumulative incidence risk in men (7.4%) and women (6.8%). Risk was underpredicted in men (-10.7%) and women (-8.2%) with frailty compared with cause-specific risk. Miscalibration occurred mostly at high predicted risk ranges. Conclusions ASCVD prediction was good in this cohort of adults aged ≥65 years. Although calibration varied by multimorbidity patterns, frailty, and competing risks, miscalibration was mostly present at high predicted risk ranges and thus less likely to alter decision making for primary prevention therapy.
背景 评估动脉粥样硬化性心血管疾病(ASCVD)风险对于预防和管理至关重要,但衰弱和多病共存的老年人中汇集队列方程的表现尚不清楚。我们评估了这些亚组中的汇集队列方程以及竞争风险的影响。 方法和结果 在来自 CHS(心血管健康研究)的 4249 名年龄≥65 岁的社区居住成年人中,我们计算了 10 年的硬 ASCVD 风险。使用 Fried 表型确定衰弱。使用潜在类别分析根据慢性疾病确定具有多种合并症模式的个体。我们使用 C 统计量评估区分度,并通过使用特定原因和累积发生率模型比较预测的 ASCVD 风险与使用特定原因和累积发生率模型估计的风险来评估校准,按多种合并症模式和衰弱状态进行评估。共有 917 名(21.6%)参与者发生 ASCVD 事件,706 名(16.6%)发生死亡竞争事件。男性的 C 统计量为 0.68,女性为 0.69;与特定原因和累积发生率估计风险相比,校准良好(男性,-0.1%和 3.3%;女性,0.6%和 1.4%)。潜在类别分析确定了 4 种模式:最小疾病、心脏代谢、认知能力低、肌肉骨骼-肺部抑郁。在心脏代谢模式中,与累积发生率风险相比,男性(7.4%)和女性(6.8%)的 ASCVD 风险被高估。与特定原因风险相比,男性(-10.7%)和女性(-8.2%)的衰弱患者的风险被低估。校准错误主要发生在高预测风险范围内。 结论 在这个≥65 岁成年人队列中,ASCVD 预测良好。尽管校准因多种合并症模式、衰弱和竞争风险而异,但在高预测风险范围内,校准错误主要发生,因此不太可能改变一级预防治疗的决策。